252 related articles for article (PubMed ID: 29802368)
1. Long-Term Administration of Conjugated Estrogen and Bazedoxifene Decreased Murine Fecal β-Glucuronidase Activity Without Impacting Overall Microbiome Community.
Chen KLA; Liu X; Zhao YC; Hieronymi K; Rossi G; Auvil LS; Welge M; Bushell C; Smith RL; Carlson KE; Kim SH; Katzenellenbogen JA; Miller MJ; Madak-Erdogan Z
Sci Rep; 2018 May; 8(1):8166. PubMed ID: 29802368
[TBL] [Abstract][Full Text] [Related]
2. Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract.
Barrera J; Chambliss KL; Ahmed M; Tanigaki K; Thompson B; McDonald JG; Mineo C; Shaul PW
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E345-54. PubMed ID: 24939737
[TBL] [Abstract][Full Text] [Related]
3. Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens.
Ervin SM; Li H; Lim L; Roberts LR; Liang X; Mani S; Redinbo MR
J Biol Chem; 2019 Dec; 294(49):18586-18599. PubMed ID: 31636122
[TBL] [Abstract][Full Text] [Related]
4. Bazedoxifene and conjugated estrogen combination maintains metabolic homeostasis and benefits liver health.
Chen KLA; Zhao YC; Hieronymi K; Smith BP; Madak-Erdogan Z
PLoS One; 2017; 12(12):e0189911. PubMed ID: 29267318
[TBL] [Abstract][Full Text] [Related]
5. Tissue-selective estrogen complexes for postmenopausal women.
Mirkin S; Komm BS
Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
[TBL] [Abstract][Full Text] [Related]
6. Gut microbial beta-glucuronidase and glycerol/diol dehydratase activity contribute to dietary heterocyclic amine biotransformation.
Zhang J; Lacroix C; Wortmann E; Ruscheweyh HJ; Sunagawa S; Sturla SJ; Schwab C
BMC Microbiol; 2019 May; 19(1):99. PubMed ID: 31096909
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study.
Flores R; Shi J; Fuhrman B; Xu X; Veenstra TD; Gail MH; Gajer P; Ravel J; Goedert JJ
J Transl Med; 2012 Dec; 10():253. PubMed ID: 23259758
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trials.
Pinkerton JV; Abraham L; Bushmakin AG; Cappelleri JC; Racketa J; Shi H; Chines AA; Mirkin S
J Womens Health (Larchmt); 2014 Jan; 23(1):18-28. PubMed ID: 24206058
[TBL] [Abstract][Full Text] [Related]
9. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
Palacios S; Currie H; Mikkola TS; Dragon E
Maturitas; 2015 Apr; 80(4):435-40. PubMed ID: 25684082
[TBL] [Abstract][Full Text] [Related]
10. Selective estrogen modulators in menopause.
Gambacciani M
Minerva Ginecol; 2013 Dec; 65(6):621-30. PubMed ID: 24346250
[TBL] [Abstract][Full Text] [Related]
11. Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model.
Naqvi H; Sakr S; Presti T; Krikun G; Komm B; Taylor HS
Biol Reprod; 2014 Jun; 90(6):121. PubMed ID: 24740602
[TBL] [Abstract][Full Text] [Related]
12. Direct and indirect effects of conjugated estrogens/bazedoxifene treatment on quality of life in postmenopausal women.
Abraham L; Bushmakin AG; Dragon E; Komm BS; Pinkerton JV
Maturitas; 2016 Dec; 94():173-179. PubMed ID: 27823739
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: insights into the unique antagonistic effects of bazedoxifene on conjugated estrogens.
Chang KC; Wang Y; Bodine PV; Nagpal S; Komm BS
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):117-24. PubMed ID: 19914376
[TBL] [Abstract][Full Text] [Related]
14. Effects of conjugated estrogens/bazedoxifene on lipid and coagulation variables: a randomized placebo- and active-controlled trial.
Skouby SO; Pan K; Thompson JR; Komm BS; Mirkin S
Menopause; 2015 Jun; 22(6):640-9. PubMed ID: 25405570
[TBL] [Abstract][Full Text] [Related]
15. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
Komm BS; Mirkin S; Jenkins SN
Steroids; 2014 Nov; 90():71-81. PubMed ID: 24929044
[TBL] [Abstract][Full Text] [Related]
16. Bazedoxifene and Conjugated Equine Estrogen: A Combination Product for the Management of Vasomotor Symptoms and Osteoporosis Prevention Associated with Menopause.
Umland EM; Karel L; Santoro N
Pharmacotherapy; 2016 May; 36(5):548-61. PubMed ID: 27027527
[TBL] [Abstract][Full Text] [Related]
17. The antagonist properties of Bazedoxifene after acute treatment are shifted to stimulatory action after chronic exposure in the liver but not in the uterus.
Buscato M; Fontaine C; Fabre A; Vinel A; Valera MC; Noirrit E; Guillaume M; Payrastre B; Métivier R; Arnal JF
Mol Cell Endocrinol; 2018 Sep; 472():87-96. PubMed ID: 29183806
[TBL] [Abstract][Full Text] [Related]
18. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
Pickar JH; Komm BS
Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
[TBL] [Abstract][Full Text] [Related]
19. Effect of conjugated estrogens and bazedoxifene on glucose, energy and lipid metabolism in obese postmenopausal women.
Marlatt KL; Lovre D; Beyl RA; Tate CR; Hayes EK; Burant CF; Ravussin E; Mauvais-Jarvis F
Eur J Endocrinol; 2020 Oct; 183(4):439-452. PubMed ID: 32698159
[TBL] [Abstract][Full Text] [Related]
20. Impact of host and environmental factors on β-glucuronidase enzymatic activity: implications for gastrointestinal serotonin.
Walsh J; Olavarria-Ramirez L; Lach G; Boehme M; Dinan TG; Cryan JF; Griffin BT; Hyland NP; Clarke G
Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G816-G826. PubMed ID: 32146834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
